Humboldt — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Metagenomimetagenomi.co in 𝕏Nov 2020

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)

BoardAndrew Farquharson(Director)inJak Knowles(Director)

Board seatSebastian Bernales· per SEC Form D

Co-investorsCatalio Capital Management, LP RA Capital Sozo Ventures Agent Capital Frazier Life Sciences InCube Ventures +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.